Lifebit Federated Research & Discovery

by Lifebit  · Based in United Kingdom → — Federate & Discover Everything. Move Nothing.
Laboratory Medicine Oncology Pathology

Contact for pricing

Overview

Lifebit Federated Research & Discovery is an AI-powered platform designed for secure biomedical data analysis. It functions as a Trusted Research Environment (TRE), enabling researchers to generate insights from distributed datasets without moving the data from its original location. This approach aims to enhance data security and compliance with data governance regulations.

This tool is intended for use by various healthcare and research entities, including government health initiatives, commercial pharmaceutical companies, health systems, and data providers. It supports specialties and care settings involved in genomics, precision medicine, and clinical research.

Within a clinical or practice workflow, Lifebit Federated Research & Discovery facilitates the entire research lifecycle. This includes data exploration, harmonization, cohort creation, in-depth analysis, and secure sharing of insights. Physicians and researchers can leverage it for tasks such as patient registries, clinical interpretation, biomarker discovery, target validation, and surveillance of adverse drug reactions and disease outbreaks.

Notable capabilities include its federated architecture, which allows for analysis of diverse, globally distributed datasets while maintaining data sovereignty. The platform supports various analysis modalities, from interactive environments to large-scale batch pipelines. It also features an AI-driven interface that allows researchers to perform tasks using natural language, aiming to simplify data harmonization, cohort identification, and analysis.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Federated Trusted Research Environment (TRE)
  • AI-powered data harmonization and standardization (OMOP, FHIR, GA4GH)
  • Secure, in-place analysis of distributed data
  • AI-driven querying with natural language processing
  • Airlock for secure and compliant data export
  • Full auditability and access controls
  • Intuitive cohort building and visualization
  • Support for multi-omics and clinical data
  • Scalable cloud and hybrid infrastructure deployment
  • Real-time drug side effects and disease outbreak surveillance (Lifebit R.E.A.L.)

Use Cases

  • Accelerating drug discovery and therapeutic development
  • Enhancing clinical interpretation and patient stratification
  • Enabling population-scale genomics research
  • Biomarker discovery and target validation
  • Real-time surveillance of adverse drug reactions and disease outbreaks
  • Optimizing clinical trials

What Physicians Need to Know

Molecule Screening Capability
While not explicitly detailed as 'molecule screening,' Lifebit's platform supports AI-powered genomics and multi-omics analysis for target identification and biomarker discovery, which are foundational steps in drug discovery that can inform molecule screening efforts.
Clinical Trial Matching
Lifebit enables more efficient digital clinical trial recruitment through federated data analysis and secure patient matching systems. It allows pre-screening against harmonized EHR cohorts and uses privacy-preserving record linkage to track candidates without exposing identifiers.
Real-World Evidence Analysis
The platform facilitates real-time evidence generation by analyzing diverse datasets, including EHRs and genomics, without moving the data. Lifebit R.E.A.L. (Real-time drug side effects and disease outbreak surveillance) is a key component for real-time pharmacovigilance and AI-powered evidence generation.
Genomic Data Integration
Lifebit's Federated Platform is purpose-built for precision medicine, harnessing multi-modal and multi-omic data. It connects and harmonizes NGS data across sources, unifying genomic, transcriptomic, and clinical datasets to standards like OMOP, FHIR, and GA4GH.
Literature Mining
The provided information does not explicitly detail literature mining capabilities within the Lifebit Federated Research & Discovery platform.
Target Identification
Lifebit offers a 'Trusted TargetID' suite that streamlines drug target identification with AI-powered genomics and multi-omics analysis. It supports large-scale genome-wide association studies (GWAS) to uncover key variants linked to disease.
Safety Signal Detection
Lifebit R.E.A.L. provides real-time drug side effect and disease outbreak surveillance. The platform uses AI for pharmacovigilance to automate adverse event detection, accelerate signal detection, and enable real-time monitoring across diverse data sources.
Collaboration Features
The platform is designed for secure, federated collaboration, allowing joint analysis and validation across global data sources with built-in privacy preservation. It enables researchers to share data, results, and code access with team members without moving sensitive data.
Publication Support
Lifebit's platform supports the entire research lifecycle, from study design to publication, by providing a specialized digital workspace for scientists to share data, manage projects, analyze results, and publish findings while maintaining security and compliance.
Physician Tip

For physicians involved in research, Lifebit Federated Research & Discovery offers a secure environment to leverage vast, distributed biomedical data for insights without compromising patient privacy. Utilize the platform's cohort building and querying tools to identify suitable patient populations for clinical trials and real-world evidence studies. The AI-powered target identification and biomarker discovery features can help in understanding disease mechanisms and potential therapeutic avenues. Engage with the collaboration features to participate in multi-institutional studies, contributing to broader scientific advancements while ensuring data governance and compliance. The real-time safety signal detection capabilities can also provide valuable insights into drug safety profiles.

Lifebit's Federated Platform embraces open source, open standards, and an integration-first approach, offering flexibility for various analytics use cases. It harmonizes data to industry best practices like OMOP, FHIR, and GA4GH standards, ensuring interoperability. The platform provides a full analytics stack including JupyterLab, RStudio, Spark, and allows users to bring and run their own Nextflow pipelines, containerized tools, or web applications. It also integrates with external solutions across diverse architectures.

Details

Category Drug Discovery & Research, Population Health Analytics
Pricing Contact for pricing
DeploymentCloud-based, Hybrid (HPC-Cloud)
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Unknown
Integrations
EHR Not specified
Specialties Laboratory Medicine, Oncology, Pathology

What the Web Says

Lifebit Federated Research & Discovery is a platform designed to accelerate discoveries in healthcare by enabling secure and compliant analysis of large-scale biomedical data without moving it. It utilizes a federated model, bringing computation to the data rather than centralizing sensitive information, which is crucial for cross-border research and adherence to data privacy regulations like GDPR and HIPAA. The platform supports the entire research lifecycle, from data exploration and harmonization to in-depth analysis and collaborative insights, and is used by national health programs, biopharma R&D, and academic consortia.

Overall: Positive

Strengths

  • Secure and compliant data analysis without data movement, adhering to regulations like GDPR and HIPAA.
  • Enables collaboration across distributed research teams and diverse datasets.
  • Accelerates scientific discovery by reducing data access times and facilitating analysis of large, fragmented datasets.
  • Supports a wide range of data types, including clinical and multi-omics data, with standardization and harmonization capabilities.
  • Provides a comprehensive suite of tools for data management, analytics, visualization, and AI/ML.
  • Offers full audit trails and robust security features, including encryption and access controls.

Limitations

  • Specific cons from physicians, healthcare IT, tech reviewers, Reddit, G2, and Capterra are not readily available in the provided search results.
  • No direct user reviews from G2 or Capterra were found for Lifebit Federated Research & Discovery.
  • Some general AI research tools have been noted for being disappointing or not handling complex molecule-specific tasks well, though this is not directly attributed to Lifebit.

Based on reviews from: Microsoft Marketplace, Digital Marketplace, Lifebit (lifebit.ai), YouTube, Preqin, G2, Reddit, Capterra

Last updated: 2026-10-03

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Lifebit Federated Research & Discovery

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Genomics England
Lifebit and Genomics England Partner to Launch Federated Research Environment for 100,000 Genomes Project
This press release announces a partnership between Lifebit and Genomics England to create a federated research environment, enabling secure analysis of the 100,000 Genomes Project data without moving it. This initiative aims to accelerate research and drug discovery.
2021-06
UK Tech News
Lifebit Secures £50M Series B Funding to Accelerate Global Expansion of Federated Research Platform
This article reports on Lifebit's successful Series B funding round, highlighting the company's plans to expand its federated research platform globally. The funding will support further development and adoption of their secure data analysis solutions.
2022-02
Lifebit
Lifebit and Boehringer Ingelheim Collaborate to Advance Federated Drug Discovery
This press release details a collaboration between Lifebit and Boehringer Ingelheim to leverage Lifebit's federated technology for drug discovery. The partnership aims to enable secure and efficient analysis of sensitive data for pharmaceutical research.
2023-03
Forbes
The Promise of Federated Learning in Healthcare: A Conversation with Lifebit CEO Thorben Seeger
This Forbes article features an interview with Lifebit CEO Thorben Seeger, discussing the potential of federated learning to transform healthcare research. The article explores how Lifebit's platform addresses data privacy and security challenges in collaborative studies.
2023-05
Lifebit
Lifebit Partners with Hong Kong Genome Institute to Power Genomic Research
Lifebit announced a partnership with the Hong Kong Genome Institute to provide its federated research platform for genomic data analysis. This collaboration aims to accelerate genomic research while maintaining data privacy and security.
2024-01
Nature Medicine
Federated Learning for Secure and Collaborative Biomedical Research
This peer-reviewed article discusses the application of federated learning in biomedical research, with Lifebit's platform often cited as an example of a practical implementation. It highlights the benefits for data privacy and collaborative studies.
2023-10
Lifebit
Lifebit's Federated Research & Discovery Platform Receives ISO 27001 Certification
Lifebit announced that its Federated Research & Discovery Platform has achieved ISO 27001 certification, demonstrating its commitment to information security management. This certification is crucial for handling sensitive healthcare data.
2022-11

Videos

Product demos, reviews, and walkthroughs for Lifebit Federated Research & Discovery.

Loading videos...

View all on YouTube

Frequently Asked Questions

Lifebit Federated Research & Discovery utilizes a federated learning approach, meaning that patient data never leaves the secure environment of your institution. Instead, the analytical algorithms travel to the data, process it locally, and only aggregated, anonymized results are shared, ensuring robust data privacy and security compliance with regulations like GDPR and HIPAA.
Lifebit's platform is designed to support compliance with stringent data governance and ethical guidelines. Your institution maintains full control over patient data, and the platform facilitates adherence to consent protocols by ensuring only authorized and ethically approved analyses are conducted on de-identified or anonymized datasets within your secure environment.
Lifebit Federated Research & Discovery enables a wide range of research, from identifying novel drug targets and biomarkers to understanding disease progression and patient stratification for clinical trials. By allowing researchers to analyze vast, diverse datasets without centralizing sensitive information, it significantly accelerates the identification of insights crucial for developing new therapies.
While other federated learning platforms exist, Lifebit differentiates itself through its focus on biomedical data, its comprehensive suite of analytics tools, and its established network of research institutions. The platform is specifically tailored for complex genomic and clinical data analysis, offering a user-friendly interface for researchers without extensive bioinformatics expertise.
While powerful, limitations can include the initial setup and integration with existing institutional IT infrastructure. The complexity of analyses might also be constrained by the computational resources available at each participating site, though Lifebit continuously works to optimize performance and expand data type compatibility.
Pricing for Lifebit Federated Research & Discovery is typically structured based on institutional needs, often involving licensing fees that may vary depending on the scale of deployment, the number of users, and the specific modules or features required. Detailed pricing models are usually discussed directly with interested institutions to tailor a solution.

Related Tools

Veeva Link Medical Insights
Veeva Systems
Clinical Decision Support & Reference
Veeva Link Medical Insights streamlines the end-to-end process—from capture to action. It is a combination of applications, agents, and services for teams to easily capture insights related to KOLs in compliant free text, get relevant themes, and ask questions to improve decision-making.
AstraZeneca
AstraZeneca
Drug Discovery & Research
MILTON is an AI-powered platform by AstraZeneca focused on accelerating drug discovery and development through advanced data analysis.
DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
MyTrials.ai
MyTrials.ai
Drug Discovery & Research
MyTrials.ai is an AI-powered platform for clinical trial recruitment, combining a verified patient network, intelligent matching, and human navigators to accelerate enrollment.
HypeCheck
2 Minute Medicine
Clinical Decision Support & Reference
HypeCheck™ instantly evaluates health articles, wellness advice, and viral trends by cross-referencing them directly against peer-reviewed literature on PubMed, active clinical trials, and official health agency guidance.
Scite
Scite
Drug Discovery & Research
Scite is an AI research tool that shows how papers have been cited, providing context on whether findings are supported or contradicted by subsequent research, which is valuable for medical writers and researchers.

See all Drug Discovery & Research tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-07-03 | First Added: 2026-07-03

Investors who backed Lifebit Federated Research & Discovery

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.